Healthy Extracts (HYEX) Receivables (2015 - 2025)
Healthy Extracts' (HYEX) quarterly Receivables came in at $187750.0 in Q4 2025, up 1606.35% year-on-year from $11003.0 in Q4 2024, and up 500.53% quarter-over-quarter from $31264.0 in Q3 2025.
Healthy Extracts (HYEX) Receivables (2015 - 2025) Analysis & Trends
Healthy Extracts' Receivables history runs 11 years deep, the most recent figure standing at $187750.0 for Q4 2025.
- On a quarterly basis, Receivables rose 1606.35% year-over-year to $187750.0 in Q4 2025; TTM through Dec 2025 was $187750.0, a 1606.35% increase from a year earlier, with the FY2025 full-year figure at $187750.0, up 1606.35% from the prior year.
- Receivables improved to $187750.0 in Q4 2025 per HYEX's latest filing, from $31264.0 in the prior quarter.
- Across five years, Receivables topped out at $187750.0 in Q4 2025 and bottomed at $3980.0 in Q2 2025.
- The 5-year median for Receivables is $87072.5 (2021), against an average of $76306.1.
- Biggest YoY gain for Receivables was 1606.35% in 2025; the steepest drop was 95.61% in 2025.
- Year by year, Receivables stood at $133340.0 in 2021, then declined by 20.66% to $105794.0 in 2022, then plunged by 71.23% to $30440.0 in 2023, then sank by 63.85% to $11003.0 in 2024, then jumped by 1606.35% to $187750.0 in 2025.
- Per Business Quant, the three latest HYEX Receivables figures stand at $187750.0 (Q4 2025), $31264.0 (Q3 2025), and $3980.0 (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 2.99 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 3.39 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 1.51 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 6.46 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 312.00 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 15.29 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 3.58 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 768.10 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 1.15 Bn |
| 10 | Healthy Extracts | 14.70 Mn | 14.56 Mn | 957,429.00 | 187,750.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 187,750.00 |
| Sep 30, 2025 | 31,264.00 |
| Jun 30, 2025 | 3,980.00 |
| Mar 31, 2025 | 69,981.00 |
| Dec 31, 2024 | 11,003.00 |
| Sep 30, 2024 | 19,766.00 |
| Jun 30, 2024 | 90,560.00 |
| Mar 31, 2024 | 24,055.00 |
| Dec 31, 2023 | 30,440.00 |
| Sep 30, 2023 | 109,224.00 |
| Jun 30, 2023 | 114,900.00 |
| Mar 31, 2023 | 135,398.00 |
| Dec 31, 2022 | 105,794.00 |
| Sep 30, 2022 | 100,755.00 |
| Jun 30, 2022 | 100,192.00 |
| Mar 31, 2022 | 109,171.00 |
| Dec 31, 2021 | 133,340.00 |
| Sep 30, 2021 | 83,585.00 |
| Jun 30, 2021 | 40,315.00 |
| Mar 31, 2021 | 24,649.00 |